Lilly direct-selling Zepbound at $499/mo — compare with 11 other programs

Compounded semaglutide vs Retatrutide

Editorial comparison of Compounded semaglutide (semaglutide (compounded)) and Retatrutide (retatrutide). Same drug class context, trial-anchored data, no marketing claims.

Reviewed by the glpzoom Editorial Team against primary clinical sources — FDA labeling, peer-reviewed trials, and specialty-society guidelines.
Content current as of June 2026; updated when guidance or availability changes.

Side-by-side

DimensionCompounded semaglutideRetatrutide
Generic namesemaglutide (compounded)retatrutide
Manufacturer503A/503B compounding pharmaciesEli Lilly
FDA approved
MechanismPharmacologically identical to branded semaglutide. Same GLP-1 receptor agonist mechanism.Where semaglutide hits one receptor and tirzepatide two, retatrutide adds a third: the glucagon receptor.
DosingSame titration as Wegovy.Investigational. Trial dosing is once-weekly subcutaneous injection with gradual titration; final approved doses are not set.
Cost$200-500/month — significantly cheaper than branded ($1,350/month). Quality varies by pharmacy; ask which 503A/B facility the compound comes from before paying.No commercial price exists. Available only via clinical-trial enrollment. Beware any website selling 'retatrutide' today, it is not a legal product.
Pivotal trial result~24% mean body-weight reduction at 48 weeks (highest dose, Phase 2)

Full Compounded semaglutide review →

Custom-compounded semaglutide. Cheaper than branded Wegovy. Not FDA-approved; legal landscape shifts.

Full Retatrutide review →

Investigational triple agonist (GLP-1 / GIP / glucagon). Phase 3 weight loss approached ~24%, the highest yet. Not FDA-approved; expected 2027.

Frequently asked

Is Compounded semaglutide or Retatrutide more effective?+

In their pivotal trials, Compounded semaglutide reported no headline result on file, while Retatrutide reported ~24% mean body-weight reduction at 48 weeks (highest dose, Phase 2). Head-to-head results vary by patient profile, dose tolerated, and adherence — these trial numbers describe averages, not what every individual experiences.

How do Compounded semaglutide and Retatrutide compare on cost?+

Compounded semaglutide: $200-500/month — significantly cheaper than branded ($1,350/month). Quality varies by pharmacy; ask which 503A/B facility the compound comes from before paying. Retatrutide: No commercial price exists. Available only via clinical-trial enrollment. Beware any website selling 'retatrutide' today, it is not a legal product. Real out-of-pocket depends on insurance formulary tier, manufacturer savings programs, and whether a direct-pay channel is available.

Can I switch from Compounded semaglutide to Retatrutide?+

Switching between brand-name treatments in the same drug class is common, but the conversion is not always 1:1. Discuss the switch with your prescriber — they'll usually re-titrate dosing rather than substitute equivalent strengths directly.

Are Compounded semaglutide and Retatrutide the same drug?+

No. Compounded semaglutide (semaglutide (compounded)) and Retatrutide (retatrutide) are distinct medications from 503A/503B compounding pharmacies and Eli Lilly respectively. They may share a drug class or mechanism but differ in active ingredient, dosing, and approved use.

We may earn a commission when you click links to partners. Affiliate disclosure.